Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897286 · ClinicalTrials.gov registry record
Study of Stored Tumor Samples in Young Patients With Brain Tumors
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Terminated
- Registry status
- 139
- Enrollment target
NCT00897286: Clinical Trial study, sponsored by St. Jude Children's Research Hospital.
NCT00897286 is a clinical trial that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897286 was terminated before completion, sponsored by St. Jude Children's Research Hospital.
- TERMINATED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This laboratory study is looking at stored tumor samples in young patients with brain tumors. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2004-11-30 |
| Est. Completion | 2025-09-25 |
Why NCT00897286 stopped before completion
NCT00897286 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00897286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897286 about?
NCT00897286 is a clinical study titled "Study of Stored Tumor Samples in Young Patients With Brain Tumors". This laboratory study is looking at stored tumor samples in young patients with brain tumors. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
What is the current status of trial NCT00897286?
This trial is currently terminated. The enrollment target is 139 participants. The study started on 2004-11-30. Estimated completion is 2025-09-25.
Who is sponsoring clinical trial NCT00897286?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI